Cimetidine (Tagamet - SKF) is the first histamine-H2 receptor antagonist in general use. It reduces gastric acid secretion and is marketed for the treatment of duodenal ulcer, benign gastric ulcer, recurrent and stomal ulceration, reflux oesophagitis and Zollinger-Ellison syndrome.
Erratum to: Can a Short Course of Prophylactic Low-Dose Proton Pump Inhibitor Therapy Prevent Stomal Ulceration after Laparoscopic Roux-en-Y Gastric Bypass?